| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Sep 20, 2023 |
Chief Financial Officer
Trans History: 2
|
Chief Financial Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Mar 06, 2023 |
General Counsel
Trans History: 4
|
General Counsel | Form 3 | Initial Statement of Beneficial Ownership of Securities | 350,000 | -- | -- |
| Mar 06, 2023 |
General Counsel
Trans History: 4
|
General Counsel | Form 3 | Initial Statement of Beneficial Ownership of Securities | 117,810 | -- | -- |
| Aug 15, 2022 |
Director
Trans History: 11
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 20,000 | $3.62 | -- |
| Jul 07, 2022 |
Director
Trans History: 18
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 44,470 | -- | -- |
| Feb 22, 2022 |
Director
Trans History: 3
|
Director | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Jun 15, 2021 |
Chief Business Officer
Trans History: 2
|
Chief Business Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Jun 08, 2021 |
Chief Commercial Officer
Trans History: 2
|
Chief Commercial Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Apr 23, 2021 |
Chief Medical Officer
Trans History: 12
|
Chief Medical Officer | Form 3/A | Amendment to an Initial Statement of Beneficial Ownership of Securities | 10,000 | -- | -- |
| Apr 23, 2021 |
Chief Medical Officer
Trans History: 12
|
Chief Medical Officer | Form 3/A | Amendment to an Initial Statement of Beneficial Ownership of Securities | 5,000 | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.